| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 32 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $110.10M | - | |
| Dir | 1.16M | $24.19M | - | |
| CEO | 368.2K | $7.68M | -2,683 | |
| Other | 169.2K | $3.53M | -887 | |
| Other | 154.2K | $3.22M | -145 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,636 | $45.12 | $118,939.40 | -0.9% | -36.4% | -73.4% | |
| Aug 19, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 2,752 | $45.12 | $124,174.42 | -1.2% | -36.4% | -73.4% | |
| Aug 19, 2024 | McNeill Jonathan55 | Chief Business Officer | Sell | 2,705 | $45.12 | $122,054.00 | -1.0% | -36.4% | -73.4% | |
| Aug 19, 2024 | Farwell Wildon55 | Chief Medical Officer | Sell | 2,321 | $45.12 | $104,726.60 | -0.8% | -36.4% | -73.4% | |
| Aug 19, 2024 | Kersten Dirk87 | Director | Sell | 248,675 | $45.48 | $11,310,183.42 | -3.3% | -36.4% | -73.4% | |
| Aug 15, 2024 | Kersten Dirk87 | Director | Sell | 281,541 | $44.76 | $12,601,535.67 | -6.1% | -25.4% | -72.9% | |
| Aug 13, 2024 | Kersten Dirk87 | Director | Sell | 212,477 | $42.93 | $9,121,901.58 | -2.4% | -35.5% | -72.0% | |
| Aug 9, 2024 | Kersten Dirk87 | Director | Sell | 183,834 | $42.85 | $7,877,090.71 | -0.5% | -32.9% | -74.4% | |
| Jun 24, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sale+OE | 39,950 | $35.09 | $1,401,901.66 | -11.8% | -2.8% | -70.2% | |
| Jun 12, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sale+OE | 40,000 | $33.36 | $1,334,200.92 | -11.4% | -1.8% | -56.2% |